Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial by Heal, Clare F et al.
RESEARCH
Does single application of topical chloramphenicol to high
risk sutured wounds reduce incidence of wound infection
after minor surgery? Prospective randomised placebo
controlled double blind trial
ClareFHeal,seniorlecturer,
1PetraGBuettner,seniorlecturer,
2RobertCruickshank,generalpractitioner,
3
David Graham, general practitioner,
3 Sheldon Browning, general practitioner,
4 Jayne Pendergast, practice
nurse,
3 Herwig Drobetz, staff orthopaedic surgeon,
5 Robert Gluer, medical student,
1 Carl Lisec, surgical
registrar
6
ABSTRACT
Objective To determine the effectiveness of a single
application of topical chloramphenicol ointment in
preventing wound infection after minor dermatological
surgery.
Design Prospective randomised placebo controlled
double blind multicentre trial.
Setting Primary care in a regional centre in Queensland,
Australia.
Participants 972 minor surgery patients.
Interventions A single topical dose of chloramphenicol
(n=488) or paraffin ointment (n=484; placebo).
Main outcome measure Incidence of infection.
ResultsThe incidenceof infectioninthe chloramphenicol
group (6.6%; 95% confidence interval 4.9 to 8.8) was
significantly lower than that in the control group (11.0%;
7.9to15.1)(P=0.010).Theabsolutereductionininfection
rate was 4.4%, the relative reduction was 40%, and the
relative risk of wound infection in the control group was
1.7(95%confidenceinterval1.1to2.5)timeshigherthan
intheinterventiongroup.Thenumberneededtotreatwas
22.8.
Conclusion Application of a single dose of topical
chloramphenicol to high risk sutured wounds after minor
surgery produces a moderate absolute reduction in
infection rate that is statistically but not clinically
significant.
Trial registration Current Controlled Trials
ISRCTN73223053.
INTRODUCTION
Chloromycetin ointment consists of 10 mg/g of
chloramphenicol in plastibase 30W and soft white
and liquid paraffin.
12 Chloramphenicol has a broad
spectrum of activity against Gram positive and Gram
negative bacteria, rickettsias, and Chlamydia.
3 Chlor-
amphenicol ointment is indicated for treatment of
bacterial conjunctivitis, but little evidence exists for its
effectiveness in prophylaxis or treatment of wound
infection. Despite this, it is regularly used in areas
outsideitsmainindication.Beforeourstudy,severalof
the investigatinggeneralpractitionershadappliedit to
sutured wounds as prophylaxis against wound infec-
tion.AsurveyofUKplasticsurgeonsreportedthat66%
used chloramphenicol eye ointment in their practice,
mainlyasprophylaxisagainstinfection.
4Theointment
hasbeenusedasanadhesiveforreplacementofthenail
bed.
5AcomprehensiveMedlinesearchfoundonlyone
other study relating to the use of topical chloramphe-
nicol ointment on wounds; this study investigated the
application of chloramphenicol ointment to wounds
after hip replacement.
6 The incidence of wound
infection in the intervention group was reduced (4% v
8%), but the sample sizewas small and the resultswere
not statistically significant.
Topicalocularchloramphenicoliswidelyusedinthe
United Kingdom and Australia for the treatment of
conjunctivitis, but is very rarely prescribed for this
indication in the United States.
7 Some controversy
previously existed about the link between aplastic
anaemia and topical ocular chloramphenicol, on the
basis of a small number of singlecase reports,
7 but two
international case-control studies provided no support
for this association. Although the association between
ocular chloramphenicol and aplastic anaemia cannot
be excluded, the risk is less than one in a million per
treatment course.
8 No incidences of aplastic anaemia
after dermatological application have been reported,
despite widespread use.
A previous study of wound infection after minor
surgery involving general practitioners in Mackay,
Queensland, showed an overall incidence of wound
infection of 8.6%.
910 This incidence was higher than
expected on the basis of the published results of a
similarAustraliangeneralpracticecohort(1.9%),askin
cancer clinic cohort (1.5%), and a European dermatol-
ogy clinic cohort (2%).
11-13 The acceptable rate of
infection after clean minor surgery is suggested to be
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14-16 The low risk of infection after clean
surgery means that studies of more than 1000
procedures (sometimes many more) are needed,
under normal circumstances, to detect a reduction in
infection from an intervention with statistical
confidence.
17Becauseofthehighincidenceofinfection
in our patient cohort, and a high minor surgery
workload,
18 we decided to use the increased capacity
to investigate a strategy to reduce the infection rate. In
this trial, we sought to establish the effectiveness of
topical chloramphenicol ointment in preventing
wound infection after dermatological surgery. We
used the Chloromycetin brand of chloramphenicol
ointmentappliedasasingledosepostoperatively,with
paraffin ointment as placebo control.
METHODS
This was a randomised controlled double blind multi-
centretrialinvolvingpatientspresentingforminorskin
excisions.
Setting and participants
We did the study in three private general practices in
Mackay, Queensland, between June 2007 and March
2008. One of the participating practices consisted of
one general practitioner working in an “open access”
designated skin cancer clinic. Fifteen doctors working
in the three practices recruited between one and 200
patients each.
We purposely selected the general practitioners as
working at practices that had previously successfully
participatedinawoundmanagementproject.
9Practice
nurses invited consecutive patients presenting for
minor skin excisions to take part in the trial. The
nurses collected demographic information on all
patients,aswellasclinicalinformationonthepresence
of diabetes or any other predetermined important
medical conditions. They used a body site map to
definetheexcisionsite.Attheendofthestudyweasked
the practice nurses to re-examine computer records to
fillinanymissingdata.Theprincipalresearchervisited
participating general practitioners and practice nurses
to provide training and ensure that recording was
standardised.
Eligibility criteria
All patients presenting to a participating general
practitioner for “minor skin excision” from all body
sites were eligibleto participatein the study.Skin flaps
andtwolayerprocedureswererecordedandincluded.
We excluded patients who were already taking oral
antibiotics, for whom oral or topical antibiotics were
clinically indicated immediately postoperatively, or
who were on immunosuppressive drugs. Other exclu-
sioncriteriawere excisionofsebaceouscyst,historyof
allergy to any of the ingredients of Chloromycetin
ointment, and personal or family history of aplastic
anaemia.
Surgical wound management protocol
We ran a workshop for participating general practi-
tioners to develop guidelines to ensure that excisions
were managed in a standardised manner. We were
unable to reach consensus about skin preparations, so
normalsalinewasusedatonecentreandchlorhexidine
at two centres. The procedure shown in box 1 was
agreed.
Intervention
We could not get information about the exact
proportions of the constituents of the base of Chlor-
omycetin ointment from the manufacturer. The
principal investigator visited a compounding pharma-
cist to develop a close match to the vehicle of the
Chloromycetin ointment by using a mixture of soft
white and liquid paraffin, prepared single doses of the
o i n t m e n ti ns t e r i l ej a r s ,a n ds t o r e dt h e mi na
refrigerator. Immediately after suturing, the doctor
applied either paraffin ointment or chloramphenicol
ointment to the sutured wounds by using sterile
forceps. Sufficient ointment was applied to cover the
surface of the wound.
Recruitment, randomisation, and blinding
We used computer generated random numbers and
opaque sealed envelopes to randomise patients. Only
the principal investigator was aware of the identity of
the coded ointments. The practice nurses enrolled
patients and assigned participants to their groups. All
participating patients received written instructions on
postoperative wound care. Both groups were asked to
Box 1 Excision procedure
1. Skin preparation—normal saline or chlorhexidine
2. Usual sterile technique (standard precautions), including sterile gloves
3. Local anaesthetic (type and volume recorded)
4. Suture material—nylon (size recorded)
5. Dressing type—melolin and tape
6. No antibiotics, either topical or oral (if required, or already prescribed, exclude from
study); no topical antiseptics, such as betadine or alcohol; no antiseptic washes or
medicated soaps
7. Removal of sutures according to body site: back—10 days; all other sites—seven days
Patient randomised
Single dose chloramphenicol 
ointment applied to sutured 
wound with sterile forceps
Single dose of paraffin 
ointment applied to sutured
wound with sterile forceps
Keep wound dry and 
covered for 24 hours
Keep wound dry and 
covered for 24 hours
After 24 hours bathe as normal
Avoid use of antiseptics
After 24 hours bathe as normal
Avoid use of antiseptics
Fig 1 | Study protocol for patients
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using antiseptics (fig 1).
Clinical outcomes
The practice nurse or the doctor assessed wounds for
infection on the agreed day of removal of sutures or
sooner if the patient re-presented with a perceived
infection. Practice nurses and doctors assessing out-
comewereblindedtotheallocationofinterventionand
control groups. We adapted our definition of wound
infection from standardised surveillance criteria for
defining superficial surgical site infections developed
by the Centre for Disease Control’s National Nosoco-
mial Infection Surveillance System (box 2).
19 We also
developed our own wound scale, after reviewing
several existing scales in the literature,
20 in order to
improve rigour. This wound scale differentiated no
infection or erythema; stitch abscess; less than 1 cm
erythema from the wound margin; greater than 1 cm
erythema from the wound margin; and deep infection
orsystemicsymptoms.Theprimaryresearcherbriefed
allparticipatingdoctorsandnursesonthedefinitionof
infection and also gave them written information. We
asked practice nurses to swab any discharging infec-
tions to investigate any pattern of antimicrobial
resistance.
Sample size
We calculated sample size on the basis of our previous
study,whichshowedaninfectionrateof8.6%.
9Onthe
basis of a projected infection rate of 10%, we decided
thatanabsolutedecreaseinincidenceofinfectionof5%
would be clinically significant. To come to this
conclusion with statistical confidence—a power in
excess of 80% and a significance level of 0.05—we
neededatotalof473patientsintheinterventiongroup
and 473 patients in the control group.
Statistical analysis
Webasedallanalysisontheintentiontotreatprinciple.
Depending on the distribution, we describe numerical
data as mean value and standard deviation or median
value and interquartile range. We present percentages
with95%confidenceintervals.Becausethesamplewas
recruitedthrough15differentgeneralpractitionersand
outcome might be more similar for patients from one
medicalprofessional(clustering)thanfromseveral,we
adjusted confidence intervals and P values for this
cluster sampling approach. Participating doctors were
the primary sampling unit, and we applied the survey
commandsofStata(release8).WeconsideredPvalues
less than 0.05 to be statistically significant.
RESULTS
Practice and study characteristics
Of the total of 1246 patients who attended for skin
excisions during the period from June 2007 to March
2008, 232 patients were excluded (table 1). Of the
remaining 1014 patients, 509 were randomised to the
intervention (chloramphenicol) group and 505 to the
placebo (paraffin) group. A total of 42 patients were
eventually lost to follow-up because they had their
sutures removed elsewhere. Follow-up was completed
in 972 (95.9%) randomised patients (fig 2).
Comparisons at baseline
Largedifferencesexistedbetweentheinterventionand
the control groups at baseline (table 2). In the
intervention group, 71.7% of patients were diagnosed
with non-melanoma skin cancer or solar keratosis
compared with 65.1% in the control group.
Incidence of infections
Infection occurred in 85 (8.7%) of the 972 excisions.
The incidence of infection in the chloramphenicol
group (6.6%; 95% confidence interval 4.9 to 8.8) was
significantly lower than the incidence in the control
group (11.0%; 7.9 to 15.1) (P=0.010; adjusted for
clustersampling).The relative risk of infection was1.7
times higher in the control group compared with the
intervention group (table 3). The number needed to
treat (number of wounds treated for each infection
prevented) was 22.8 (488/21.4).
We found no significant difference in the wound
score between the control and intervention groups
(P=0.253),although5.5%ofpatientsshowederythema
greater than 1 cm in the intervention group compared
with 9.1% of patients in the control group (table 3).
Wound swabs were done for 24 of the 85 infections.
These revealed Staphylococcus aureus infections that
were resistant to benzylpenicillin but sensitive to all
other antibiotics in 22 cases. In one case, additional
resistance to erythromycin but sensitivity to all other
antibiotics was noted. In another case, Pseudomonas
Box 2 Definition of surgical site infection
 Infection must be within 30 days of excision
 Purulent discharge from the wound must be present, or
The general practitioner must diagnose a wound infection, or
The general practitioner prescribes antibiotics
 Stitch abscess must not be counted as an infection
Patients presenting during study period (n=1246)
Randomised (n=1014) Excluded (n=232)*
Lost to follow-up (n=21) Lost to follow-up (n=21)
Chloramphenicol (n=509)
Non-compliance (n=1)
Placebo (paraffin) (n=505)
Non-compliance (n=4)
Analysed (n=488) Analysed (n=484)
Fig2 | Flowchartofenrolment,randomisation,andfollow-upof
patients. *See table 1 for reasons for exclusions
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two swabs were taken from patients in the control
group.
DISCUSSION
The results of this study suggest that a single dose of
topical chloramphenicol to sutured wounds can
produce a relative reduction in infection rate of about
40%.Theabsolutereductionwas4.4%,whichfellshort
of our pre-determined reduction for clinical relevance
(5%), so this was essentially a negative trial. The
incidence of infection in our control group (11%) is
much higher than reported in the published literature
looking at similar cohorts.
11-13 The intervention thus
may not produce a worthwhile absolute reduction in
infection in low risk settings where infection rates are
already low; the number needed to treat in these
circumstanceswouldbemuchhigherthanourfigureof
22.8.
Limitations
The study had several limitations. Various character-
istics influence the occurrence of infections; although
we recorded information on as many variables as
possible, ensuring that the baseline data were compar-
able proved difficult. For example, inadequate data
were recorded on suture size and occupation, so we
could not compare these factors. In addition, the
prevalence of diabetes and of other medically impor-
tant conditions was probably under-recorded, and
powertoanalysethesesubgroupswaslimited.Surgical
training and technique of the general practitioners
involved is a potential confounder that would be
difficult to quantify and was not recorded. However,
we adjusted the statistical analysis for the cluster
sampling, taking the doctor as the primary sampling
unit. The type of skin preparation used by the three
participating practices differed, but we found no
previously published evidence that this makes any
differencetoinfectionrates.
21Atotalof42participants
were lost to follow-up. If all 21 participants who were
lost to follow-up in the intervention group had
developed an infection, the rates of infection in both
groups would have been similar (10.4% and 11.0%);
however, we believe that this scenario is extremely
unlikely.
Diagnosis of infection—even when guidelines are
used—is still subjective, and inter-observer and intra-
observervariationmayoccur.
20Thedefinitionweused
is the most widely implemented standard definition of
wound infection,
19 and by developing our own wound
assessmentscalewehopedtoreducethesubjectivityof
diagnosisofinfection.Wehavenoevidencetosupport
the intra-practice and inter-practice reproducibility of
measurement and recording procedures.
Thestudydidnothaveanarminwhichnoointment
was applied, so we do not know if the ointment itself
had any pro-infective or anti-infective properties. The
ointment base of Chloromycetin consists of a mixture
of soft white paraffin, liquid paraffin, and plastibase
30W,whichisaplasticisedhydrocarbongelconsisting
of 95% mineral oil and 5% polyethylene glycol. We
could not get information about the exact proportions
of these constituents from the manufacturer. Our
placebo ointment consisted of 50% soft white paraffin
and 50% liquid paraffin and was not completely
identical to the ointment base of Chloromycetin as it
did not contain plastibase 30W. We cannot determine
if thissubstancehasaneffectoninfection,althoughwe
think that this is unlikely. Our trial used only a single
doseofchloramphenicolointment.Wehavenoreason
to surmise that repeated doses might lead to a greater
reduction in infection rate.
Table 2 |Baseline comparisons of intervention (chloramphenicol) and control (paraffin) groups.
Values are numbers (percentages) unless stated otherwise
Characteristics Intervention group (n=488) Control group (n=484)
Patients
Mean (SD) age (years) 59.5 (23.2) 59.0 (27.5)
Male 266 (54.5) 262 (54.1)
Smoking status:
Never smoked 298 (61.1) 299/483 (61.9)
Ex-smoker 109 (22.3) 108/483 (22.4)
Current smoker 81 (16.6) 76/483 (15.7)
Diabetes mellitus 37 (7.6) 50/483 (10.4)
With medical condition* 79/478 (16.5) 86/475 (18.1)
Lesions
Body site:
Neck and face 166 (34.0) 152 (31.4)
Upper extremities 139 (28.5) 140 (28.9)
Trunk 108 (22.1) 102 (21.1)
Lower extremities 75 (15.4) 90 (18.6)
Histology:
Melanoma and naevi 64 (13.1) 74 (15.3)
Non-melanoma skin cancer and
precursor
350 (71.7) 315 (65.1)
Other† 74 (15.2) 95 (19.6)
Procedures
Mean (SD) length of excision (mm) 20.9 (25.6) 21.0 (28.8)
Median (interquartile range) No of
days until removal of sutures
7( 7 - 9 ) 8( 7 - 1 0 )
With flap 1 (0.2) 3 (0.6)
With two level procedure 4 (0.8) 4 (0.8)
*Chronic obstructive pulmonary disease (n=14), aspirin or clopidogrel (n=120), oral steroids (n=3), continuous
inhaled steroids (n=9), warfarin (n=42), ischaemic heart disease (n=7), peripheral vascular disease (n=6), and
c u r r e n tc a n c e r( n =21).
†Included seborrhoeic keratosis, re-excisions of melanoma and basal cell carcinoma, sebaceous cyst,
epidermal cyst, wart, and dermatitis.
Table 1 |Reasons for exclusion from study
Reasons No (%) patients (n=232)
Patient declined participation 139 (60)
Patient on oral antibiotics 39 (17)
Doctor did not follow study protocol 20 (9)
History of allergy to Chloromycetin 2 (1)
Patient did not plan to return for removal of sutures 12 (5)
Shave biopsy done 6 (3)
Patient on immunosuppressive drug 4 (2)
Patient with infected sebaceous cyst 10 (4)
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Some limits to generalising these findings exist. The
populationofMackayisslightlyolderthanthegeneral
Australian population and has a lower median house-
hold income.
22 Mackay is a provincial town in tropical
NorthQueensland.Theclimateishotandhumid,with
a mean daily maximum temperature ranging between
24.2°C and 30°C during the summer months and a
relative humidity of 75-79%.
23 These tropical condi-
tions could increase sweat production and produce
damp dressings, which might reduce the effectiveness
of wound dressings as a potential barrier against
exogenous bacteria.
24-26 This would make wounds
more prone to infection in a tropical environment, so
the results may not necessarily be generalisable to a
temperate climate, although no published evidence
shows that heat and humidity increase infection rates.
This might also explain why our infection rates were
higherthansuggestedbypreviousdatafromtemperate
climates.
11-13
Antibiotic use
Some concern exists about the overuse of topical
antibioticsresultinginantibioticresistance.Britishand
Australian guidelines suggest that use of topical anti-
biotics should be restricted because of the capacity of
most topical drugs to select resistant micro-organisms
and to cause sensitisation. The guidelines also suggest
that antimicrobials recommended for topical use
should be selected from classes not in use for systemic
treatment.
327 A contrary argument says that the
potential for antimicrobial resistance with topical
antibiotics is actually lower than with systemic anti-
biotics because of the higher local concentration
achieved by topical delivery.
28 Patterns of
antimicrobial activity and resistance have been exam-
ined for other antibiotic ointments.
2930 However, no
evidence exists, over three decades of extensive use
worldwide, to show that, with the exception of
mupirocin, topical antibiotics administered on an
outpatient basis contribute to any emerging resistance
pattern.
28 Chloramphenicol eye drops have been
shown to be effective in the treatment of meticillin
resistant Staphylococcus aureus ocular surface
infections.
31
Some concern also exists about the incidence of
allergic contact dermatitis with use of topical anti-
biotics.Fortopicalneomycin,thishasbeenshowntobe
as high as 11% in a population referred for diagnostic
patch testing.
32 However, some evidence shows that
the incidence of this reaction is as low as 1% when the
ointment is used in the general population.
28 The
reaction is much more common among patients
previously exposed to neomycin ointment.
32 Contact
allergy has been reported with the use of chloramphe-
nicol ointment, but the incidence is thought to be
low.
3334 Although any connection between the use of
topical chloramphenicol and aplastic anaemia is
unlikely,
78 our study was not large enough to fully
assess the risk in this setting.
Antibioticprophylaxisisprobablyprescribedexces-
sively or inappropriately for dermatological surgery
and is thought to be best reserved for patients at high
risk.
193536 No data are available on the current
prescribing habits of Australian general practitioners
regarding oral or topical antibiotic prophylaxis for
minor excisions. Although no evidence is available on
what reduction in the rate of infection we might
reasonably expect from the use of oral prophylactic
antibioticsforminorexcisions,someevidenceshowsa
50% reduction in risk of infection when perioperative
oralantibioticprophylaxisisusedaftercleansurgery.
17
A similar reduction in infection rate from a singledose
of topical antibiotic, as in this study, may encourage a
reduction in the use of oral antibiotics.
The decision to prescribe antibiotic prophylaxis is
complicated; in addition to efficacy, the antibiotic
costs, adverse effects, and resistance should be taken
intoaccount.However,insomecircumstances,topical
delivery of antibiotic may be preferable to systemic
administration.
327 The results of this study could
encourage the judicial use of topical antibiotics after
minor skin surgery. However, topical
Table 3 |Incidence of wound infections in intervention (chloramphenicol) and control (paraffin) groups
Infections Intervention group (n=488) Control group (n=484) Combined results (n=972)
No of infections 32 53 85
Incidence of infection 6.6% 11.0% 8.7%
Relative risk (95% CI) of infection 1 (reference category) 1.7 (1.1 to 2.5) NA
Wound score: (n=487) (n=483) (n=970)
Stitch abscess 14 (2.9%) 14 (2.9%) 28 (2.9%)
<1 cm erythema 67 (13.8%) 62 (12.8%) 129 (13.3%)
>1 cm erythema 27 (5.5%) 44 (9.1%) 71 (7.3%)
NA=not applicable.
WHAT IS ALREADY KNOWN ON THIS TOPIC
A survey of UK plastic surgeons showed that 66% use chloramphenicol ointment in some
capacity
A small pilot study suggested that chloramphenicol ointment might reduce the incidence of
wound infection
No published studies have been done in a primary care setting
WHAT THIS STUDY ADDS
Asingleapplicationoftopicalchloramphenicoltohighrisksuturedwoundsreducedinfection
by 40%
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 5 of 6chloramphenicol would be unlikely to produce a
worthwhile absolute reduction in infection rates in
low risk settings in developed countries. Future
research could explore the possibility that important
reductions may be seen in higher risk wounds or in
more resource poor settings.
Conclusion
This study suggests that application of a single dose of
topical chloramphenicol to high risk sutured wounds
after minor surgery produces a moderate absolute
reduction in infection rate.
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